Amgen, Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Amgen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2036
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Amgen, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Amgen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Amgen, Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Amgen, Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Amgen, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Amgen, Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Amgen, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Amgen, Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Amgen, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 12
Corporate Venturing – Overview 12
Corporate Venturing – Deal reports 13
PARTNERSHIP 17
Partnership – Overview 17
Partnership – Deal reports 18
CAPITAL RAISING 103
Capital Raising – Overview 103
Capital Raising – Deal reports 104
APPENDIX 107
Contact Us 107
About MarketLine Financial Deals Database 107
Deal Definition and Methodology 109
About MarketLine 116

List of Tables
Table 1: Amgen Inc M&A volume and value trend (2014-YTD2018)
Table 2: Amgen Inc M&A activity by geography (2014-YTD2018)
Table 3: Amgen Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Amgen Inc corporate venturing by geography (2014-YTD2018)
Table 5: Amgen Inc partnership volume and value trend (2014-YTD2018)
Table 6: Amgen Inc partnership trend by key deal type (2014-YTD2018)
Table 7: Amgen Inc capital raising volume and value trend (2014-YTD2018)
Table 8: Amgen Inc capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Amgen Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Amgen Inc M&A activity by geography (2014-YTD2018)
Figure 3: Amgen Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Amgen Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Amgen Inc partnership volume and value trend (2014-YTD2018)
Figure 6: Amgen Inc partnership trend by key deal type (2014-YTD2018)
Figure 7: Amgen Inc capital raising volume and value trend (2014-YTD2018)
Figure 8: Amgen Inc capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Amgen, Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • TESARO Inc (TSRO):製薬・医療:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • NCC AB:戦略・SWOT・企業財務分析
    NCC AB - Strategy, SWOT and Corporate Finance Report Summary NCC AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Indiana Municipal Power Agency:電力:M&Aディール及び事業提携情報
    Summary Indiana Municipal Power Agency (IMPA) is a not-for-profit wholesale power provider supplying power to cities and communities across Indiana and Ohio. The agency was formed by its member utilities which enable them to share power resources and provide electricity economically to their custome …
  • Power Financial Corporation:企業の戦略・SWOT・財務情報
    Power Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Power Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • UCL Business PLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the trans …
  • Axon Enterprise, Inc.:戦略・SWOT・企業財務分析
    Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report Summary Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Link Health Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Link Health Group (Link Health) is a pharmaceutical company focused on the discovery and development of novel drug candidates for the treatment of cancer and other diseases. Its pipeline product portfolio includes LH011, an oral small molecule serine protease inhibitor for treating pancreati …
  • Spicejet Limited
    Spicejet Limited - Strategy, SWOT and Corporate Finance Report Summary Spicejet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Pharmacyclics LLC:企業の戦略的SWOT分析
    Pharmacyclics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bioceros BV-製薬・医療分野:企業M&A・提携分析
    Summary Bioceros BV (Bioceros) is a biopharmaceutical company which provides services related to preclinical development of monoclonal antibodies. The company offers GMP-ready protein producing cell lines. The company provides services which include monoclonal antibody generation, cell line and proc …
  • Bespak Europe Ltd:企業の製品パイプライン分析2018
    Summary Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems. The company provides products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator …
  • Akorn Inc (AKRX):企業の財務・戦略的SWOT分析
    Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • salesforce.com, inc.:戦略・SWOT・企業財務分析
    salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report Summary salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Selvita SA (SLV):製薬・医療:M&Aディール及び事業提携情報
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆